Literature DB >> 19840361

Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.

Y-K Kim1, R Nieuwlaat, S J Connolly, S Schulman, K Meijer, N Raju, S Kaatz, J W Eikelboom.   

Abstract

BACKGROUND: The efficacy and safety of vitamin K antagonists for the prevention of thromboembolism are dependent on the time for which the International Normalized Ratio (INR) is in the therapeutic range. The objective of our study was to determine the effect of introducing a simple two-step dosing algorithm, as compared with dosing by anticoagulation clinic staffs on the basis of their experience, on time in therapeutic range (TTR) of warfarin therapy.
METHODS: We compared TTRs of all clinic patients before and after the introduction of a simple two-step dosing algorithm at a single anticoagulation clinic in Canada, between 1 August 2006 and 24 December 2008. TTR was calculated using the linear interpolation method of Rosendaal.
RESULTS: We included 873 patients in the 'before' phase and 1088 patients in the 'after' phase. Introduction of the dosing algorithm significantly increased TTR of patients with a therapeutic INR range of 2-3 from 67.2% to 73.2% (P < 0.001), and that of patients with a therapeutic INR range of 2.5-3.5 from 49.8% to 63.8% (P < 0.001).
CONCLUSIONS: The introduction of a simple two-step warfarin-dosing algorithm in place of dosing by experienced anticoagulation clinic staff significantly improved mean TTR for patients in a tertiary-care anticoagulation clinic. This inexpensive and widely applicable algorithm has the potential to improve warfarin control.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840361     DOI: 10.1111/j.1538-7836.2009.03652.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  19 in total

1.  Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy.

Authors:  Jessica L Cohen; Elena Thompson; Liron Sinvani; Andrzej Kozikowski; Guang Qiu; Renee Pekmezaris; Alex C Spyropoulos; Jason J Wang
Journal:  J Thromb Thrombolysis       Date:  2019-11       Impact factor: 2.300

Review 2.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Warfarin: its highs and lows.

Authors:  Zack Dumont; Merunka Mordasiewicz; Lynette Kosar; Brenda Schuster
Journal:  Can Fam Physician       Date:  2013-08       Impact factor: 3.275

4.  Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients.

Authors:  Martin A Bishop; Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

5.  Non-genetic factors and polymorphisms in genes CYP2C9 and VKORC1: predictive algorithms for TTR in Brazilian patients on warfarin.

Authors:  Marcus Fernando S Praxedes; Maria Auxiliadora P Martins; Aline O M Mourão; Karina B Gomes; Edna A Reis; Renan P Souza; Emílio Itamar F Campos; Daniel D Ribeiro; Manoel Otávio C Rocha
Journal:  Eur J Clin Pharmacol       Date:  2019-11-12       Impact factor: 2.953

6.  Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario.

Authors:  Devendra Saksena; Yugal K Mishra; S Muralidharan; Vivek Kanhere; Pankaj Srivastava; C P Srivastava
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-28

7.  Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices.

Authors:  Robby Nieuwlaat; John W Eikelboom; Sam Schulman; Harriette G C van Spall; Karleen M Schulze; Benjamin J Connolly; Spencer M Cuddy; Lowiek M Hubers; Alexander C Stehouwer; Stuart J Connolly
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

8.  Novel oral anticoagulants versus warfarin therapy at various levels of anticoagulation control in atrial fibrillation--a cost-effectiveness analysis.

Authors:  Joyce H S You
Journal:  J Gen Intern Med       Date:  2013-10-17       Impact factor: 5.128

9.  Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation.

Authors:  Alberto Tosetto; Cesare Manotti; Francesco Marongiu
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

10.  Warfarin and atrial fibrillation: from ideal to real the warfarin affaire.

Authors:  Mauro Molteni; Claudio Cimminiello
Journal:  Thromb J       Date:  2014-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.